Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Jeong Hwan Park, Jung Ho Kim

Clin Mol Hepatol. 2019;25(1):12-20. Published online October 5, 2018

DOI: https://doi.org/10.3350/cmh.2018.0067

View: 24422 Download: 1,098 Web of Science: 37 Crossref: 40

Meyoung Cho, M.D., Chang Soo Choi, M.D., Geom Seog Seo, M.D., Tae Hyeon Kim, M.D., Suck Chei Choi, M.D., Ki Jung Yun, M.D. Haak Cheoul Kim, M.D.

Clin Mol Hepatol. 2007;13(2):234-238. Published online January 1, 1970

View: 2644 Download: 22

Ji Hoon Kim , Joong Won Park , Joon Il Choi , Hyun Beom Kim , Dong Wook Koh , Woo Jin Lee , Chang Min Kim

Clin Mol Hepatol. 2007;13(1):91-95. Published online January 1, 1970

View: 2812 Download: 19

Min An, M.D., Jeong A Shin, M.D., Sang-Min Lee, M.D., Tak Yoon, M.D. Weon Seo Park, M.D. Joon Il Choi, M.D., and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2006;12(4):562-567. Published online January 1, 1970

View: 2748 Download: 29

1 |

Viewed By 5493	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4668	MAFLD: How is it different from NAFLD?
Viewed By 4395	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3613	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3570	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search